Sleep Duration and the Risk of Breast Cancer: the Ohsaki Cohort Study

Overview

Journal Br J Cancer

Specialty Oncology

Date 2008 Sep 25

PMID 18813313

Citations 81

Authors

M Kakizaki

S Kuriyama

T Sone

K Ohmori-Matsuda

A Hozawa

N Nakaya

S Fukudo

I Tsuji

Affiliations

Soon will be listed here.

Abstract

In a prospective study of 23 995 Japanese women, short sleep duration was associated with higher risk of breast cancer (143 cases), compared with women who slept 7 h per day, the multivariate hazard ratio of those who slept </=6 h per day was 1.62 (95% confidence interval: 1.05-2.50; P for trend=0.03).

Citing Articles

Neuroscience of cancer: unraveling the complex interplay between the nervous system, the tumor and the tumor immune microenvironment.

Huang Q, Hu B, Zhang P, Yuan Y, Yue S, Chen X Mol Cancer. 2025; 24(1):24.

PMID: 39825376 PMC: 11740516. DOI: 10.1186/s12943-024-02219-0.

A narrative review of sleep and breast cancer: from epidemiology to mechanisms.

Zhang B, Tang M, Li X Cancer Causes Control. 2024; .

PMID: 39731679 DOI: 10.1007/s10552-024-01951-8.

The role of circadian clock in regulating cell functions: implications for diseases.

Lin Y, He L, Cai Y, Wang X, Wang S, Li F MedComm (2020). 2024; 5(3):e504.

PMID: 38469551 PMC: 10925886. DOI: 10.1002/mco2.504.

Sleep disorders and cancer incidence: examining duration and severity of diagnosis among veterans.

Burch J, Delage A, Zhang H, McLain A, Ray M, Miller A Front Oncol. 2024; 14:1336487.

PMID: 38469244 PMC: 10927008. DOI: 10.3389/fonc.2024.1336487.

Relationship of sleep-quality and social-anxiety in patients with breast cancer: a network analysis.

He C, He Y, Yang T, Wu C, Lin Y, Yan J BMC Psychiatry. 2023; 23(1):887.

PMID: 38017507 PMC: 10683122. DOI: 10.1186/s12888-023-05262-1.

References

Feychting M, Osterlund B, Ahlbom A . Reduced cancer incidence among the blind. Epidemiology. 1998; 9(5):490-4. View

Blask D, Wilson S, Zalatan F . Physiological melatonin inhibition of human breast cancer cell growth in vitro: evidence for a glutathione-mediated pathway. Cancer Res. 1997; 57(10):1909-14. View

Tsuji I, Nishino Y, Ohkubo T, Kuwahara A, Ogawa K, Watanabe Y . A prospective cohort study on National Health Insurance beneficiaries in Ohsaki, Miyagi Prefecture, Japan: study design, profiles of the subjects and medical cost during the first year. J Epidemiol. 1999; 8(5):258-63. DOI: 10.2188/jea.8.258. View

Verkasalo P, Pukkala E, Stevens R, Ojamo M, Rudanko S . Inverse association between breast cancer incidence and degree of visual impairment in Finland. Br J Cancer. 1999; 80(9):1459-60. PMC: 2363081. DOI: 10.1038/sj.bjc.6690544. View

Parkin D, Bray F, Ferlay J, Pisani P . Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55(2):74-108. DOI: 10.3322/canjclin.55.2.74. View

Schernhammer E, Hankinson S . Urinary melatonin levels and breast cancer risk. J Natl Cancer Inst. 2005; 97(14):1084-7. DOI: 10.1093/jnci/dji190. View

Megdal S, Kroenke C, Laden F, Pukkala E, Schernhammer E . Night work and breast cancer risk: a systematic review and meta-analysis. Eur J Cancer. 2005; 41(13):2023-32. DOI: 10.1016/j.ejca.2005.05.010. View

Verkasalo P, Lillberg K, Stevens R, Hublin C, Partinen M, Koskenvuo M . Sleep duration and breast cancer: a prospective cohort study. Cancer Res. 2005; 65(20):9595-600. DOI: 10.1158/0008-5472.CAN-05-2138. View

Pukkala E, Ojamo M, Rudanko S, Stevens R, Verkasalo P . Does incidence of breast cancer and prostate cancer decrease with increasing degree of visual impairment. Cancer Causes Control. 2006; 17(4):573-6. DOI: 10.1007/s10552-005-9005-6. View

10.

Pinheiro S, Schernhammer E, Tworoger S, Michels K . A prospective study on habitual duration of sleep and incidence of breast cancer in a large cohort of women. Cancer Res. 2006; 66(10):5521-5. DOI: 10.1158/0008-5472.CAN-05-4652. View

11.

Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y . Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA. 2006; 296(10):1255-65. DOI: 10.1001/jama.296.10.1255. View

12.

Schwartzbaum J, Ahlbom A, Feychting M . Cohort study of cancer risk among male and female shift workers. Scand J Work Environ Health. 2007; 33(5):336-43. DOI: 10.5271/sjweh.1150. View

13.

Marugame T, Matsuda T, Kamo K, Katanoda K, Ajiki W, Sobue T . Cancer incidence and incidence rates in Japan in 2001 based on the data from 10 population-based cancer registries. Jpn J Clin Oncol. 2007; 37(11):884-91. DOI: 10.1093/jjco/hym112. View

14.

Schernhammer E, Berrino F, Krogh V, Secreto G, Micheli A, Venturelli E . Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 2008; 100(12):898-905. PMC: 2630389. DOI: 10.1093/jnci/djn171. View

15.

Wu A, Wang R, Koh W, Stanczyk F, Lee H, Yu M . Sleep duration, melatonin and breast cancer among Chinese women in Singapore. Carcinogenesis. 2008; 29(6):1244-8. PMC: 2574570. DOI: 10.1093/carcin/bgn100. View

16.

Kliukiene J, Tynes T, Andersen A . Risk of breast cancer among Norwegian women with visual impairment. Br J Cancer. 2001; 84(3):397-9. PMC: 2363754. DOI: 10.1054/bjoc.2000.1617. View

17.

Schernhammer E, Laden F, Speizer F, Willett W, Hunter D, Kawachi I . Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J Natl Cancer Inst. 2001; 93(20):1563-8. DOI: 10.1093/jnci/93.20.1563. View

18.

Schernhammer E, Schulmeister K . Melatonin and cancer risk: does light at night compromise physiologic cancer protection by lowering serum melatonin levels?. Br J Cancer. 2004; 90(5):941-3. PMC: 2409637. DOI: 10.1038/sj.bjc.6601626. View

19.

Martin J, Klein D . Melatonin inhibition of the neonatal pituitary response to luteinizing hormone-releasing factor. Science. 1976; 191(4224):301-2. DOI: 10.1126/science.1108199. View

20.

Wehr T . The durations of human melatonin secretion and sleep respond to changes in daylength (photoperiod). J Clin Endocrinol Metab. 1991; 73(6):1276-80. DOI: 10.1210/jcem-73-6-1276. View